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During our phylogenetic evolution we have selected genes, the so called thrifty genes, that can help to maximize
the amount of energy stored from every consumed calorie. An imbalance in the amount of stored calories can lead
to many diseases. In the early 80’s the distinguished English epidemiologist David Barker, formulated a hypothesis
suggesting that many events that occur during the intrauterine life and early in infancy can influence the
occurrence of many diseases that will develop in adulthood. This theory proposes that under-nutrition and other
insult or adverse stimulus in utero and during infancy can permanently change the body’s structure, physiology and
metabolism. The lasting or lifelong effects of under-nutrition will depend on the period in the development at
which it occurs. The clues that led Barker to his conclusions started to be discovered when he was studying the
temporal trends in the incidence of ischemic heart disease in England and Wales. Examining data found in The
Hertfordshire records, collected in the beginning of the last century, he found that the rates of mortality by
ischemic heart disease was much higher in children born in less affluent counties and mostly in those with low
birth weight. After his initial findings a myriad of diseases have been found to be linked to low birth weight and
under-nutrition in utero and in the neonatal period. These diseases were then nominated adult diseases with fetal
origin. Epidemiological studies that led to these findings suggest that in utero and early postnatal life have critical
importance for long-term programming of health and disease, opening unique chances for primary prevention of
chronic diseases.Introduction
In order to understand what we weight from our intra-
uterine life until adulthood, we must understand our
genes. It is supposed that at least 24.000 genes constitute
the human blueprint and that over 250 of these genes
may help determine our weight [1].
About 40.000 years ago, somewhere in the world, a
Paleolithic couple emerged to become the great, great,
great… grandparents of us all. Their genes still inhabit our
cells, and we continue to pass them from one generation
to the next, and these genes still shape our metabolic
pathways. We must look to our Paleolithic ancestors to
understand the modern-day problems of obesity, diabetes
and many other diseases. We must look to these genes to
know why the environment we have created is so aggres-
sive to our health. We must understand how and why the
genes that were advantageous in the past are so deleteri-
ous now [1].* Correspondence: carlosnegrato@uol.com.br
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distribution, and reproduction in any mediumOur ancestors were nomads. They used to travel long
distances in search of food. The food sources were unreli-
able and no one ever knew exactly where or when they
would get the next meal. When food was present, espe-
cially like fat and protein of animal origin, to store calories
within the body was a very wise strategy [1].
Paleolithic men were possibly lean, muscular and
strong. Their bodies evolved to withstand the danger
that was everywhere. They used to have vigorous phys-
ical activity and insufficient food was a constant risk [1].
Women like the men used to be physically active and
in order to supplement what men brought back home,
they gathered nuts, berries, fruits, vegetables and roots.
Obesity supposedly did not exist, because the food sup-
ply was so uncertain [1].
We cannot be certain, but possibly the Paleolithic diet
was approximately 30 percent protein that came from
fish and meat. We can certainly assume that the mam-
mals our ancestors ate were also lean; they probably did
not live in feedlots or graze on carefully managed pas-
tures. They had to exert themselves to obtain food and
to avoid becoming the meal of some other animal. SoCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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ition was largely composed by muscles [1].
Our ancestors’ diet possibly consisted of up to 100 grams
of fiber per day, what is 5–10 times higher than is typical
today. Fat corresponded to approximately 20 percent and
was mostly unsaturated since it used to come from nuts
and seeds. Since the meat was also lean, Paleolithic diet was
minimally composed by saturated fat [1].
Paleolithic men and women did not live long, possibly
less than 20 years. If they survived birth and infancy,
most died in what we consider today young adulthood.
They were vulnerable to famine, predators, accidents
and infections; the women faced all this plus the risk of
childbirth. We can certainly assume that our ancestors
did not have health problems obesity-related that plague
us today. Because of their low fat intake, their blood ves-
sels were probably free of fat deposits and stroke; heart
attacks and high blood pressure were possibly rare. Dia-
betes and obesity were not known those days. Also, by
not living so long, they would not have time to develop
chronic diseases [1].Thrifty genes
The genes of our Paleolithic ancestors evolved for people
who spent their days in constant physical activity and
whose diet was low in calories and in saturated fat. Al-
though, evolution selected genes that could support
times of a poor food supply of a poor food supply, long
winters and long times of recurrent droughts. These
genes were called thrifty genes because they helped to
maximize the amount of energy that could be obtained
and stored from every consumed calorie [1,2].
One possible mechanism for accomplishing this was
insulin resistance (IR) that was an adaptive condition for
babies, before and after birth, in order to use few calo-
ries more efficiently. In times when food was more
abundant, these genes would enable these babies to eat
more and stock body fat for the future hard times that
would certainly come. When food was scarce these
genes would preserve those fat stores, slowing down
metabolism and keeping the body’s energy reserves [1,2].
Thrifty genes were advantageous for life in the
Paleolithic era. About 10.000 years ago, the world began
to change. Many humans developed agriculture, domes-
ticated animals, left behind their nomadic way of life,
settled down and developed cities and civilizations.
Famines became less frequent and the nutritional envir-
onment became altered. Humans started to eat more
grains and consequently less fish, fruits and vegetables.
Animals started to be raised in enclosed spaces and also
became fatter. The saturated fat they contained was less
favorable to the human metabolism and cardiovascular
system [1,2].It seems that these thrifty genes became less important
in societies with better climate and abundant supplies.
This helps to explain why obesity and diabetes for
example, are more common in some parts of the world
than in others [1,2].The scars of early life
In the 1980’s, Barker developed a hypothesis according
which many nutritional events that occur during the
intrauterine life and early in infancy will influence the
development of adult diseases. This became the so called
Barker hypothesis [3].
Lucas, proposed the term “programming” to describe
the process by which an adverse event happening at a
critical period of development, has long lasting or life-
long significance [4]. Fetal programming opened the
field for extensive research into the fetal origin of adult
diseases. The association between low birth weight
(LBW), which reflects intrauterine nutritional status, and
the development of adult diseases has been confirmed in
many studies for type 2 diabetes (T2D), hypertension
(HT) and ischemic heart diseases (IHD) [1-4]. These
findings will be presented in this review.
Barker’s hypothesis suggests that under-nutrition and
other insult or adverse stimulus in utero and during
infancy can permanently change the body’s structure,
physiology and metabolism. The lasting or lifelong
effects of under-nutrition will depend on the period in
the development at which it occurs. In early gestation it
will reduce body’s size permanently, whereas in late ges-
tation it will have deep effects on body form without
necessarily reducing body size. Fetuses and neonates that
are rapidly growing are more vulnerable to under-
nutrition. These effects include altered gene expression,
reduced cell numbers, imbalance between cell types,
altered organ structure, pattern of hormonal release and
hormonal responses [5]. Thus, the tendencies of our
body to become obese, to develop T2D and many other
diseases in the adulthood are affected by our genes, our
early development and our lifestyle [1].
The clues that led Barker, a distinguished epidemiolo-
gist to formulate his hypothesis started to be discovered
when he was studying the temporal trends in the inci-
dence of IHD in England and Wales [5,6].
The incidence of IHD increased rapidly in the western
world in the beginning of the 20th century, and in the
present days it has been growing in the so called devel-
oping countries such as China, India, Russia and in
many eastern European countries. Such abrupt changes,
in a so short time frame, could not be explained by gen-
etic changes, and then the attention of the scientists was
directed to the existing lifestyle in the industrialized
countries. The relationship of IHD with obesity, smoking
Negrato and Gomes Diabetology & Metabolic Syndrome 2013, 5:49 Page 3 of 8
http://www.dmsjournal.com/content/5/1/49habit, high cholesterol levels and stress among many
other factors have been well established [5,6].
In 1977, Forsdahl has found considerable variations in
the rates of mortality from IHD in twenty Norwegian coun-
ties. He has suggested that these variations could not be
explained by the current differences in standard of living
existing then. Such differences did exist in the past as was
shown by large variations in infant mortality. A significant
positive correlation has been found between the county
age-adjusted mortality from IHD in people aged between
40 and 69 years and county’s infant mortality relating to the
early years in the same cohorts. His findings suggested that
great poverty in childhood and adolescence followed by
prosperity, was a risk factor for IHD [7].
Studying the geographic distribution of mortality by
IHD, Barker has found that although the rise in IHD in
England and Wales has been associated with increasing
prosperity, paradoxically, mortality rates by IHD were
higher in the least affluent areas. A strong geographical
relation between IHD mortality rates in 1968–78 and
infant mortality in 1921–25 was observed. IHD was
found to be strongly correlated with both neonatal and
postneonatal mortality rates. These findings led him also
to suggest that poor nutrition in early life increases sus-
ceptibility to the effects of an affluent diet [3].
Barker concluded then that under-nutrition in women
in childbearing age could be the origin of high rates of
IHD in the next generation, since it would impair a
woman’s ability to nourish her baby in utero and in early
infancy [5,6].
The Hertfordshire records
In order to test the hypothesis that IHD is programmed in
utero, it was necessary to study people now, in middle and
late life whose early growth had been recorded some-
where. Barker then undertook a search for medical re-
cords of babies born in the early 1900s, with the staff from
the Medical Research Council of Britain. They searched
archives and hospital record departments throughout the
country. Many were found; some were in large collections
preserved for many years, some had no more then a few
hundred records that were kept by a clinic or a midwife.
Some were found in lofts, sheds, garages, boiler rooms or
flooded basements. Finally, in Hertfordshire, a county lo-
calized in the East region of England, just north of
London, the appointments made by Ethel Margaret
Burnside, the first county’s chief health visitor and lady in-
spector of midwives were found. She set up an army of
trained nurses to attend women in childbearing age and to
advise mothers about their babies health [5].
From 1911 onwards, when a woman in Hertfordshire
had a baby, she was attended by a midwife that visited
her home at regular intervals to get information about
the baby’s health and development. The weight wasrecorded at birth and at one year of age, when visits
ceased. From 1923 onwards the health visitors continued
their visits until the child was five years old. The ledgers
containing these information were maintained until
1945. They were found by the Medical Research Council
in 1986 [5].
With the data found in Hertfordshire ledgers, Barker
used records from England’s National Health Service to
trace about 16.000 men and women who had been born
in this county between 1911 and 1930. He then matched
information about their current health status to the
infant data that were collected by Burnside’s nurses. In
1989 when his study was published, 3.865 people had
already died with ages ranging from 20 to 74 years. He
observed that the mortality by IHD is almost two times
more prevalent in those that had a birthweight ≤ 2.500 g
when compared to those who had a birthweight ≥
4.000 g. Barker discovered that men who had been small
at birth, and who were still small at age one, were at the
highest risk of presenting IHD. The mortality rates by
any other disease had no relation to the birthweight [6].
Subsequent research throughout the world, has found
similarly strong associations between LBW and IHD
[8-10].
Thrifty phenotype hypothesis or the
small-baby-syndrome
The ‘thrifty phenotype’ hypothesis was proposed based on
studies which showed that individuals who had a LBW
(small babies) have an increased risk of developing symp-
toms of the metabolic syndrome (MS), T2D and cardiovas-
cular diseases (CVD) later on [11]. This hypothesis, had the
following two premises: 1) LBW is an indicator of maternal
and, consequently, fetal under-nutrition, and 2) phenotypic
characteristics that lead to a ‘saving’ of energy are beneficial
for the individual in conditions of poor postnatal nutrition.
Essentially, this hypothesis proposes that prenatal under-
nutrition leads to decreased insulin secretion and, simultan-
eously, IR in the fetus which, in turn slows down prenatal
weight gain. This phenotype results from active fetal adap-
tations and is preserved for the life span of affected individ-
uals [11]. Accordingly, in later life such a phenotype must
be ‘thrifty’ and help affected individuals to cope better with
conditions of food shortage. However, under affluent condi-
tions in modern western societies this advantage turns into
a disadvantage and leads to the MS, T2D and CVD [11].
A small for gestational age (SGA) is a full term baby
who is under 2.500 g at birth or born with a birth weight
and/or length under two standard deviations (2 SDs) for
the gestational age and sex of the population [12]. The
determination of gestational age is generally difficult, be-
ing the most precise those performed with ultra-sound,
while those assessed from the time of last normal men-
strual period are deceivable [13,14].
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affected, their birth length (SGA-l) or both (SGA-w/l).
These subgroups achieve final height in different ways.
SGA-w born children are mostly likely to achieve catch-up
growth after the second year of life, while SGA-w/l chil-
dren more frequently remain short in adulthood [15].
A growth retardation is a failure that can occur during
the intrauterine development and is called intrauterine
growth retardation (IUGR). If this condition is detected,
both mother and fetus should undergo adequate moni-
toring by fetal biometry and doppler ultrasonography of
uterine and fetal blood vessels [12].
The general incidence of SGA newborns is 3-10%
[16-18]. In a study conducted in the USA in 2004 with
95.000 healthy newborns, 2.3% were SGA. The rate of
LBW for the entire studied population (4.112.052) was
8.1% [19].
Etiology of the small-baby-syndrome or small for
gestational age
Most patients born SGA do not have a clear etiology for
this condition to happen. Nevertheless, several maternal
and fetal conditions have been identified as causative
factors for the birth of a SGA baby.
Maternal factors can be related to insufficient substrate
supply to the fetus during development due to many
different causes such as reduced maternal food intake,
maternal systemic diseases such as HT and diabetes,
periodontal disease, abnormal placental function that can
lead to an impaired utero-placental blood supply or dis-
ruption of the placental transfer, abruption, infarction or
mal-development of the placenta. The majority of these
factors can influence growth during the last trimester of
pregnancy and result predominantly in IUGR that refers
to poor growth of a baby while in the mother’s womb
during pregnancy [20-23]. Other maternal contributing
factors to SGA are: parity, ethnicity, delivery at age less
than 16 and more than 35 years and previous history of
SGA born children. Parents size seems to be less im-
portant on the baby’s birth weight [24].
The exposure of the fetus to a toxic intrauterine milieu
caused by tobacco, alcohol consumption or illicit drugs
abuse increase the risk of SGA or IUGR births. Smoking
during pregnancy has the most significant influence with
a relative risk of 3.24 [21,25].
Several fetal factors are related to the birth of a SGA
baby, like some chromosomal anomalies such as gonadal
disgenesy, Edward Syndrome, Turner Syndrome, Down
Syndrome and Prader-Willi Syndrome [24].
The thrifty phenotype seems to be strongly associated
with the birth of a SGA baby. Several mechanisms have
been proposed to explain growth retardation of the
fetus and the infant. The growth is assumed to be
altered both quantitatively and qualitatively by a poornutritional environment. Metabolic disturbances depend
on the period of gestation in which a famine affected
the mother and the children, as a Dutch SGA study
showed in examining the population who suffered from
famine during the Second World War [26,27]. If fetal
exposure occurs during early pregnancy it will affect
lipid metabolism, but if it occurs in late pregnancy, it
will affect the glucose metabolism [26]. It is supposed
that an inadequate development of pancreatic beta cell
mass and their function are the link between poor fetal
nutrition, IR and T2D later in life. A thrifty phenotype
is adapted to survive in poor nutritional circumstances.
Later in adulthood, abundant food intake and decreased
energy expenditure lead towards obesity, glucose intoler-
ance and HT among many other diseases, caused by
epigenetic alterations that occurred during the intrauter-
ine life [11,28,29].
How can it matter fifty or more years late that a
person was born small? Nowadays, there is compel-
ling evidence linking epigenetic factors to many hu-
man diseases. Epigenetic factors, by different types of
reactions, could mediate the interplay between genes
and environment resulting in activation or repression
of genetic transcription, or even silencing the genetic
transcription. The most important epigenetic reac-
tions affecting genetic transcription are acetylation
and methylation. These reactions occur mainly in the
tail of histones that are proteins where DNA is
wrapped. Brownlee et al. have demonstrated in hu-
man aortic endothelial cells, that excessive concentra-
tion of reactive oxygen species (ROS) can induce
monomethylation of lysine from histone 3 increasing
the expression of the subunit p65 of nuclear factor
kappa beta. This reaction is responsible for the
increased transcription of vascular cell adhesion mol-
ecule 1 and monocyte chemoattractant molecule 1
that are both related to diabetes, hypertension and
other components of the MS [30,31].
Plagemann et al., have recently demonstrated in ani-
mal models that the neonatally acquired adipogenic and
diabetogenic phenotype can probably be caused, at least
in part, by over-nutrition in pre-and/or neonatal period,
that can lead to alterations of DNA methylation pat-
terns within the promoter regions of genes whose prod-
ucts are involved in the hypothalamic regulation of
appetite, body weight and metabolism. In the promoter
region of proopiomelanocortin (POMC), the most
important anorexigenic neurohormone, neonatally
overfed rats develop hypermethylation of activating
transcription factor binding sites, in parallel with
hypomethylation at an inhibitory transcription factor
binding site. The promoter region of the hypothalamic
insulin receptor gene promoter was found to be
hypermethylated. These studies suggest that perinatal
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betes risk due to neonatal over-nutrition may occur via
altered methylation patterns of the promoter regions of
central nervous body weight-regulating neuropeptides
and receptors [32-34].Consequences of the small-baby-syndrome or small for
gestational age for newborns, infants and adolescents
During the newborn period SGA babies present
increased risk of hypoglycemia, hypothermia, hyper-
coagulability, hyperbilirubinemia, hypotension, necrotiz-
ing enterocolitis, respiratory distress syndrome, lower
Apgar scores, umbilical artery acidosis, more intubations
and complications during delivery and approximately 20
times increased risk of neonatal death than babies born
with an appropriate for gestational age (AGA) weight
[24,35-37].
In the first two years of life, about 90–95% of children
born SGA present catch-up growth [38]. More than 80%
of SGA infants achieve catch-up growth during the first
six months of life [39]. Ponderal index at birth is not re-
lated to postnatal catch-up growth in infants born SGA,
but birth length and target (parental) height are import-
ant. The genetic influence on catch-up growth appears
to start from the onset of childhood. For SGA children,
being born short or becoming short during the first two
years of life is similar in terms of risk for adult short
stature [40].
In the childhood years, about 10% of children born
SGA do not achieve catch-up growth after the second
year of life and remain short (≤ 2 SDs) during childhood,
adolescence and adulthood [38,41]. The risk of short
final adult height was found to be five times higher for
children with LBW and seven times higher for those
with low birth length compared with children with nor-
mal birth size. At age 20, men and women were 4.50 cm
and 3.94 cm, respectively, shorter than those born with
AGA, and also have raised insulin and proinsulin levels
which could be markers of early changes in insulin
sensitivity [41].
Children born SGA seem to have modest independent
effects on learning, cognition, and attention in adoles-
cence [42]. They also have a greater risk of being
psychosocially disadvantaged, less socially competent
and present more behavioral difficulties due to impair-
ments of neurocognitive and educational development
and also specific adaptation difficulties towards short
stature [43]. These children also present low scores of
alertness, mood instability, significant differences in
academic and professional achievements [44].
Children born SGA present early and rapid start of
puberty; the amplitude of pubertal spurt is small, and
they reach their final height earlier than children bornwith AGA. Girls have an advanced menarche by 5–10
months and boys have more genital alterations [38].
Consequences of the small-baby-syndrome or small for
gestational age for adults
After Barker’s findings of the strong associations be-
tween LBW and IHD it was suggested that many
diseases of adulthood could have a fetal origin. Many
subsequent studies have shown the association between
LBW and a higher risk of developing several adult
diseases.
In 1976, Ravelli et al., have conducted a historical
cohort study of 300.000 19-year-old men exposed to the
Dutch famine of 1944–45 and examined at military
induction. They have found that outcomes were opposite
depending on the time of exposure. During the last
trimester of pregnancy and the first months of life,
exposure to famine produced significantly lower obesity
rates, suggesting that nutritional deprivation affected a
critical period of development for adipose-tissue cellular-
ity. During the first half of pregnancy, however, exposure
resulted in significantly higher obesity rates consistent
with the inference that nutritional deprivation affected
the differentiation of hypothalamic centers regulating
food intake and growth [45].
Many other conditions have been identified such as an
increased risk of T2D [11,46,47] and IR with a decreased
insulin-stimulated glucose uptake [48]; high death rates
from IHD [49,50]; higher risk of developing MS [51-53];
CVD and HT independently of genetic factors, shared
familial environment, and risk factors for HT in adult-
hood, including body mass index [54-57]; dyslipidemia
with an atherogenic lipid profile [58-60] and obesity
[61,62]. All these findings have been confirmed in many
distinct populations such as in USA [63], Sweden [64],
France [65], Norway [66] and Finland [67]. The associ-
ation between LBW and T2D was found to be strong
even after correction for many risk factors and it is inde-
pendent of the degree of obesity and frequency and
intensity of physical activity [68].
Epidemiological evidence of this casual relationship
has been extended to many other diseases such as higher
risk of breast cancer [69,70], end-stage renal disease
mainly during the first 14 years of life [71,72], osteopor-
osis [73,74], spontaneous hypothyroidism [75], adult
asthma [76], cardiac hypertrophy [77], depression [78],
male reproductive health problems, including hypospa-
dias, cryptorchidism and testicular cancer [38,79], liver
cirrhosis [80], adult schizophrenia [81], adult hearing
loss [82], polycystic ovary syndrome and precocious
pubarche [83].
The phenotype that seems to be more strongly associ-
ated to higher risks of adult diseases is LBW followed by
a fast catch-up growth [84-86].
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A clear phenomenological association has been demon-
strated by many epidemiological studies between LBW
and increased risk later in life, for many diseases such as
IR, mortality by IHD, MS, T2D, CVD, HT, dyslipidemia,
obesity, breast and testicular cancer, end-stage renal
disease, osteoporosis, spontaneous hypothyroidism, adult
asthma and hearing loss, cardiac hypertrophy, depres-
sion, liver cirrhosis, schizophrenia, polycystic ovary
syndrome, precocious pubarche, hypospadias, crypt-
orchidism, low scores of alertness, mood instability,
significant differences in academic and professional
achievement. Probably, perinatally acquired alterations
of DNA methylation patterns of gene promoters of
central nervous regulators of body weight and metabol-
ism play a key role in mediating these relationships. In
conclusion, under-nutrition during neonatal life plays a
critical role, beyond prenatal development, in the long-
term programming of health and disease. This opens a
variety of opportunities and challenges to primarily pre-
vent chronic diseases such as stature deficits, endocrine,
metabolic and neurodevelopmental disturbances during
childhood and several diseases as those above men-
tioned, during adulthood.
This should be appropriately considered in future
health care policies as well as research programs. Pre
and neonatal under-nutrition should be avoided to pre-
vent long-term deleterious consequences. Further stud-
ies are suggested to evaluate epigenomic mechanisms
such as alterations of DNA methylation, that potentially
underlie the increased risks for all these diseases.
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